Enterprise Value
6.184M
Cash
416K
Avg Qtr Burn
-3.245M
Short % of Float
4.58%
Insider Ownership
8.01%
Institutional Own.
1.32%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PURE EP™ (device) Details Medical device, Heart disease | Approved Quarterly sales | |
Merimepodib (MMPD) Details COVID-19 | Failed Discontinued |